DJIA 17,757.91 138.40 0.79%
NASDAQ 5,013.12 26.26 0.53%
S&P 500 2,077.42 14.31 0.69%
market minute promo


11.62 -0.38 (-3.17%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ZIOP $11.62 -3.17%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.12
Previous Close $12.00
Daily Range $11.49 - $12.46
52-Week Range $2.31 - $14.40
Market Cap $1.5B
P/E Ratio -13.33
Dividend (Yield) $0.00 (0.0%)
Volume 2,715,863
Average Daily Volume 3,399,725
Current FY EPS -$0.43




Drug Makers

ZIOPHARM Oncology (ZIOP) Description

ZIOPHARM Oncology Inc. is a biopharmaceutical company engaged in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies. Website:

News & Commentary Rss Feed

What Is Cancer Immunotherapy?

Cancer immunotherapy is rapidly becoming a major new weapon in the fight against this deadly disease. Here is a brief primer on this powerful new technology, as well as a look at where it's likely headed moving forward.

Trade-Ideas: ZIOPHARM Oncology (ZIOP) Is Today's Post-Market Leader Stock

Intrexon Corp is expanding its business

Intrexon Corp is expanding his business

CAR T-Cell Stocks a Better Way to Leverage Biotech Than New 3x ETFs

Will ZIOPHARM Oncology (ZIOP) Stock Decline After Analyst Downgrade?

Barbarian At The Gate: ZIOPHARM Oncology (ZIOP)

Ziopharm Oncology Downgraded By BMO As 'Questions Persist'

CAR T-Cell Biotechs Look Exciting, But A Word Of Caution On Safety

Perilous Reversal Stock: ZIOPHARM Oncology (ZIOP)

See More ZIOP News...

ZIOP's Top Competitors

ZIOP $11.62 (-3.17%)
Current stock: ZIOP
AMGN $154.99 (0.96%)
Current stock: AMGN
GILD $116.01 (-0.91%)
Current stock: GILD
BIIB $405.41 (0.36%)
Current stock: BIIB